ResearcherHospital of the University of PennsylvaniaNo recent work listed

Annika Lisbeth Windon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-3265-7563; OpenAlex author ID A5031297558. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2018: 1 paper

Papers 1

A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/jgo.2017.10.14 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stuti G. Shroff · 1 shared paper, 2018 · strength 0.10
- Paper A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. DOI 10.21037/jgo.2017.10.14 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.